News

Dr. Reddy’s announces senior level changes

BY Ryan Chavis

HYDERABAD, India — Dr. Reddy’s Labs on Wednesday announced that it has named Satish Reddy as chairman of the board. Reddy previously held the position of vice-chairman, managing director & COO. GV Prasad will continue to serve as CEO and provide leadership to the company in an executive capacity. He has also been named co-chairman and managing director.

“Satish is actively involved in various industry associations and leads the Corporate Social Responsibility efforts at Dr. Reddy’s,” Prasad said. “In his new role, he can contribute significantly to shaping the direction and course of action on these fronts, in addition to being a custodian of the corporate brand and driving governance processes and agenda of the board.”

Additionally, the company also announced that Abhijit Mukherjee, president of global generics, has been appointed as COO. Mukherjee will be responsible for both the global generics and pharmaceutical services and active Ingredients businesses.

“I look forward to working closely with Abhijit and the team in the drive towards science- and innovation-based leadership at Dr. Reddy’s,” Prasad added.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Tiger Balm to be premier sponsor of the Avon Walk for Breast Cancer Chicago

BY Michael Johnsen

HAYWARD, Calif. — Tiger Balm U.S. on Wednesday announced its third year as a premier sponsor of the Avon Walk for Breast Cancer Chicago. The two-day walk takes place May 31 and June 1 between Soldier Field and Horner Park.

“For nearly 100 years, Tiger Balm has been committed to providing relief from pain and suffering,” stated Kenneth Yeung, president of Prince of Peace Enterprises, the sole licensed United States distributor for all Tiger Balm products. “The Avon Walks provide vital support to people suffering from breast cancer, and we are honored to join Avon and the people of Chicago in our common fight against this terrible disease.”

As part of its sponsorship, Tiger Balm U.S. will distribute free samples of Tiger Balm Ultra Strength Ointment from its tent at the Avon Wellness Village on the first day of the Walk.

Tiger Balm U.S. is also providing a photo booth kiosk where Walk participants can pose for free souvenir photos to mark the significance of the day. Participants will receive a printed photo and will also be able to share their photos via email, text message or social media.

Additionally, Tiger Balm U.S. will give away three gift packs filled with $300, $200 or $100 worth of Tiger Balm U.S. products and gear. Walk participants can enter to win by following @Tiger_Balm_US on Twitter and tweeting a photo or Vine video from the event. The photo or video should feature themselves at the Tiger Balm U.S. tent, or elsewhere at the event with the free sample, and the tweet must include the hashtags #TigerBalm and #AvonWalksCH.

Tiger Balm U.S. is also sponsoring two other Avon Walk for Breast Cancer events in 2014, including the walks in San Francisco (July 12 and 13) and New York (October 18 and 19).

In addition to sponsoring key local events, Tiger Balm U.S. is raising awareness for the Avon Walk message on a national level by including Avon stickers on the packaging of Tiger Balm Neck & Shoulder Rub and Tiger Balm Pain Relieving Patch.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
News

Mylan launches olanzapine tablets

BY Ryan Chavis

PITTSBURGH — Mylan on Wednesday announced that it has launched olanzapine orally disintegrating tablets in 5-mg, 10-mg, 15-mg and 20-mg strengths. The drug is the generic version of Zyprexa Zydis tablets from Eli Lilly and Co.

The drug is used for the treatment of schizophrenia or the acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. Olanzapine ODT had U.S. sales of $120.8 million for the 12 months ending March 31, 2014, according to IMS Health.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?